Cargando…

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study

Introduction: The objective was to investigate the diagnostic accuracy of different thresholds of the soluble vascular endothelial growth factor receptor-1 (sFlt-1) and the placental growth factor (PlGF) in preterm (≤37 weeks) and term (>37 weeks) preeclampsia (PE). Materials and Methods: A neste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huhn, Evelyn A., Kreienbühl, Andrea, Hoffmann, Ina, Schoetzau, Andreas, Lange, Soeren, Martinez de Tejada, Begona, Hund, Martin, Hoesli, Irene, Lapaire, Olav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284367/ https://www.ncbi.nlm.nih.gov/pubmed/30560128 http://dx.doi.org/10.3389/fmed.2018.00325

Ejemplares similares

Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study
por: Huhn, Evelyn A., et al.
Publicado: (2020)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
por: Hastie, Roxanne, et al.
Publicado: (2022)

Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women
por: Sovio, Ulla, et al.
Publicado: (2017)

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study
por: Gao, Jinsong, et al.
Publicado: (2021)

Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?
por: Vokalova, Lenka, et al.
Publicado: (2018)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
por: Rădulescu, Carmen, et al.
Publicado: (2016)

Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia
por: Kolla, Varaprasad, et al.
Publicado: (2012)

An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia
por: Hassan, Mahmoud Fathy, et al.
Publicado: (2013)

Predictive value of soluble fms‐like tyrosine kinase‐1 against placental growth factor for preeclampsia in a Chinese pregnant women population
por: Yu, Fan, et al.
Publicado: (2019)

Stimulation of Monocytes by Placental Microparticles Involves Toll-Like Receptors and Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells
por: Joerger-Messerli, Marianne Simone, et al.
Publicado: (2014)

Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
por: Sánchez-Aranguren, Lissette C., et al.
Publicado: (2018)

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia
por: Bian, Xuming, et al.
Publicado: (2019)

Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
por: Powers, Robert W., et al.
Publicado: (2010)

Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review
por: Kosinska-Kaczynska, Katarzyna, et al.
Publicado: (2020)

Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2008)

Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting
por: Zeisler, H., et al.
Publicado: (2019)

How Soluble Fms-Like Tyrosine Kinase 1 Could Contribute to Blood-Brain Barrier Dysfunction in Preeclampsia?
por: Torres-Vergara, Pablo, et al.
Publicado: (2022)

Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
por: Dupont, Vincent, et al.
Publicado: (2022)

Second-trimester urine nephrin:creatinine ratio versus soluble fms-like tyrosine kinase-1:placental growth factor ratio for prediction of preeclampsia among asymptomatic women
por: Zhai, Tianyue, et al.
Publicado: (2016)

Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy–associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1–placental growth factor ratio in the early second trimester
por: Huang, Tianhua, et al.
Publicado: (2023)

Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1)
por: Neuman, Rugina I., et al.
Publicado: (2022)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II
por: Murphy, Sydney R, et al.
Publicado: (2015)

Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
por: Mayer-Pickel, Karoline, et al.
Publicado: (2019)

Long-term observational study of renal outcome after preeclampsia: Role of soluble fms-like tyrosine kinase-1(sFlt-1)/ placental growth factor (PlGF) and endoglin
por: Thitivichienlert, Thanaphan, et al.
Publicado: (2022)

Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
por: Hahn, Sinuhe, et al.
Publicado: (2015)

Placental Findings in Preterm and Term Preeclampsia: An Integrative Review of the Literature
por: Pietro, Luciana, et al.
Publicado: (2021)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
por: Kifle, Meron M., et al.
Publicado: (2022)

Placental Protein 13 (Galectin-13) Polarizes Neutrophils Toward an Immune Regulatory Phenotype
por: Vokalova, Lenka, et al.
Publicado: (2020)

Role of the Uteroplacental Renin–Angiotensin System in Placental Development and Function, and Its Implication in the Preeclampsia Pathogenesis
por: Yart, Lucile, et al.
Publicado: (2021)

Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome
por: Stepan, Holger, et al.
Publicado: (2020)

Potential markers of preeclampsia – a review
por: Grill, Simon, et al.
Publicado: (2009)

Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy
por: Selvarajan, Sathya, et al.
Publicado: (2019)

Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks’ gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study
por: MacDonald, Teresa M., et al.
Publicado: (2018)

Calcitonin gene-related peptide protects from soluble fms-like tyrosine kinase-1-induced vascular dysfunction in a preeclampsia mouse model
por: Mishra, Akansha, et al.
Publicado: (2023)

T2* Placental Magnetic Resonance Imaging in Preterm Preeclampsia: An Observational Cohort Study
por: Ho, Alison E.P., et al.
Publicado: (2020)

Pseudogene fms-related tyrosine kinase 1 pseudogene 1 (FLT1P1) cooperates with RNA binding protein dyskeratosis congenita 1 (DKC1) to restrain trophoblast cell proliferation and angiogenesis by targeting fms-related tyrosine kinase 1 (FLT1) in preeclampsia
por: Chi, Zhenjing, et al.
Publicado: (2021)

Augmented Placental Protein 13 in Placental-Associated Extracellular Vesicles in Term and Preterm Preeclampsia Is Further Elevated by Corticosteroids
por: Kazatsker, Marina Marks, et al.
Publicado: (2023)

Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study
por: Mitlid-Mork, Birgitte, et al.
Publicado: (2020)

Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD
por: Zsengellér, Zsuzsanna K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_80ml9tfr4o1hqmon9pjkp2mfre